Replies to post #544591 on NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Larppis, this looks like the right trial. If it is, LL did not show poly ICLC on the chart, unless I simply missed it as the talk progressed. Anyway, if it does include poly ICLC then the extra efficacy up to about 60% without reaching the median could be attributed to Keytruda. Still positive for Merk.

BTW, spellcheck always wants to change your name to something completely different, like Alleppo. My apologies ahead of time if I miss the change.